| APAF1 |
O14727
|
apoptotic peptidase activating factor 1
|
|
9.6E-06 |
0.525 |
0.769 |
| FAS |
P25445
|
Fas cell surface death receptor
|
|
0.81 |
0.372 |
0.923 |
| BCL6 |
P41182
|
BCL6 transcription repressor
|
|
0.96 |
0.444 |
0.808 |
| BCL7A |
Q4VC05
|
BAF chromatin remodeling complex subunit BCL7A
|
|
7.8E-02 |
0.736 |
0.385 |
| PRDM1 |
O75626
|
PR/SET domain 1
|
|
0.96 |
0.538 |
0.731 |
| BMI1 |
P35226
|
BMI1 proto-oncogene, polycomb ring finger
|
|
0.94 |
0.448 |
0.808 |
| CD19 |
P15391
|
CD19 molecule
|
|
0.90 |
0.430 |
0.885 |
| CD28 |
P10747
|
CD28 molecule
|
|
0.36 |
0.436 |
0.885 |
| TNFRSF8 |
P28908
|
TNF receptor superfamily member 8
|
|
0.86 |
0.444 |
0.808 |
| CD40 |
P25942
|
CD40 molecule
|
|
0.85 |
0.396 |
0.846 |
| CD44 |
P16070
|
CD44 molecule (Indian blood group)
|
|
2.4E-07 |
0.363 |
0.962 |
| CD47 |
Q08722
|
CD47 molecule
|
|
0.92 |
0.468 |
0.769 |
| CD58 |
P19256
|
CD58 molecule
|
|
0.25 |
0.584 |
0.769 |
| CD59 |
P13987
|
CD59 molecule (CD59 blood group)
|
|
0.61 |
0.469 |
0.808 |
| CD81 |
P60033
|
CD81 molecule
|
|
0.92 |
0.555 |
0.846 |
| CDKN1A |
P38936
|
cyclin dependent kinase inhibitor 1A
|
|
1.9E-03 |
0.403 |
0.769 |
| CDKN1B |
P46527
|
cyclin dependent kinase inhibitor 1B
|
|
0.62 |
0.409 |
0.769 |
| CDKN2A |
P42771 Q8N726
|
cyclin dependent kinase inhibitor 2A
|
|
0.39 |
0.300 |
0.885 |
| CDKN2B |
P42772
|
cyclin dependent kinase inhibitor 2B
|
|
7.3E-03 |
0.417 |
0.769 |
| CR2 |
P20023
|
complement C3d receptor 2
|
|
4.7E-19 |
0.556 |
0.654 |
| CSF3 |
P09919
|
colony stimulating factor 3
|
|
0.38 |
0.377 |
0.885 |
| CXADR |
P78310
|
CXADR Ig-like cell adhesion molecule
|
|
0.37 |
0.454 |
0.885 |
| DDIT3 |
P35638
|
DNA damage inducible transcript 3
|
|
0.59 |
0.467 |
0.846 |
| NQO1 |
P15559
|
NAD(P)H quinone dehydrogenase 1
|
|
1.2E-09 |
0.434 |
0.885 |
| DNMT3B |
Q9UBC3
|
DNA methyltransferase 3 beta
|
|
0.20 |
0.453 |
0.846 |